Insider Transactions in Q4 2022 at Tracon Pharmaceuticals, Inc. (TCON)
Insider Transaction List (Q4 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 29
2022
|
Scott B. Brown CHIEF FINANCIAL OFFICER |
BUY
Open market or private purchase
|
Direct |
3,500
+13.93%
|
$3,500
$1.49 P/Share
|
Dec 21
2022
|
William R Larue Director |
SELL
Open market or private sale
|
Direct |
120
-1.52%
|
$120
$1.26 P/Share
|
Dec 14
2022
|
Opaleye Management Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
167,500
+4.57%
|
$167,500
$1.25 P/Share
|
Dec 14
2022
|
Charles Theuer PRESIDENT AND CEO |
BUY
Open market or private purchase
|
Direct |
23,000
+6.46%
|
$23,000
$1.29 P/Share
|
Dec 06
2022
|
Opaleye Management Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,539
-0.04%
|
$1,539
$1.44 P/Share
|
Dec 06
2022
|
Opaleye Management Inc. > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
221,539
+5.23%
|
$0
$0.01 P/Share
|
Nov 18
2022
|
Charles Theuer PRESIDENT AND CEO |
BUY
Open market or private purchase
|
Direct |
13,900
+4.29%
|
$13,900
$1.41 P/Share
|
Nov 03
2022
|
Charles Theuer PRESIDENT AND CEO |
BUY
Open market or private purchase
|
Direct |
9,200
+3.01%
|
$9,200
$1.52 P/Share
|
Nov 02
2022
|
Charles Theuer PRESIDENT AND CEO |
BUY
Open market or private purchase
|
Direct |
6,000
+2.05%
|
$6,000
$1.59 P/Share
|
Oct 18
2022
|
Opaleye Management Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
12,500
+0.16%
|
$12,500
$1.65 P/Share
|
Oct 07
2022
|
Charles Theuer PRESIDENT AND CEO |
BUY
Open market or private purchase
|
Direct |
5,000
+1.77%
|
$5,000
$1.77 P/Share
|
Oct 03
2022
|
Charles Theuer PRESIDENT AND CEO |
BUY
Open market or private purchase
|
Direct |
5,000
+1.8%
|
$5,000
$1.67 P/Share
|